Clopidogrel for the hot patient.
作者信息
Bilodeau Matthew L, Simon Daniel I
出版信息
Circ Cardiovasc Interv. 2009 Dec;2(6):495-6. doi: 10.1161/CIRCINTERVENTIONS.109.921577.
Abstract
摘要
相似文献
1
Clopidogrel for the hot patient.
Circ Cardiovasc Interv. 2009 Dec;2(6):495-6. doi: 10.1161/CIRCINTERVENTIONS.109.921577.
2
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
Circ Cardiovasc Interv. 2009 Dec;2(6):503-12. doi: 10.1161/CIRCINTERVENTIONS.109.879312. Epub 2009 Nov 17.
3
Stent thrombosis after drug eluting stent implantation.
Circ J. 2011;75(6):1316-7. doi: 10.1253/circj.cj-11-0407. Epub 2011 Apr 29.
4
Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.
Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6.
5
Clopidogrel under scrutiny.
Catheter Cardiovasc Interv. 2008 Dec 1;72(7):925-6. doi: 10.1002/ccd.21871.
6
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
Thromb Haemost. 2010 Dec;104(6):1193-200. doi: 10.1160/TH10-05-0266. Epub 2010 Sep 13.
7
[Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
Minerva Med. 2003 Apr;94(2):XIII-IV.
8
Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI.
Clin Res Cardiol. 2011 Oct;100(10):907-14. doi: 10.1007/s00392-011-0321-4. Epub 2011 Apr 30.
9
Coronary artery disease: Platelet activity: an obstacle for successful PCI.
Nat Rev Cardiol. 2009 Jun;6(6):391-2. doi: 10.1038/nrcardio.2009.76.
10
Time dependence of clopidogrel loading effect: platelet activation versus platelet aggregation.
Thromb Res. 2012 Jan;129(1):1-2. doi: 10.1016/j.thromres.2011.07.048. Epub 2011 Aug 20.
引用本文的文献
1
Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?
Curr Rheumatol Rep. 2014 Feb;16(2):403. doi: 10.1007/s11926-013-0403-6.
本文引用的文献
1
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
Circ Cardiovasc Interv. 2009 Dec;2(6):503-12. doi: 10.1161/CIRCINTERVENTIONS.109.879312. Epub 2009 Nov 17.
2
The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
J Am Coll Cardiol. 2009 Aug 18;54(8):669-77. doi: 10.1016/j.jacc.2009.03.076.
3
Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study.
J Am Coll Cardiol. 2006 Dec 5;48(11):2186-91. doi: 10.1016/j.jacc.2005.12.084.
4
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.
Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1648-52. doi: 10.1161/01.ATV.0000225288.74170.dc. Epub 2006 May 4.
5
Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting.
Am J Cardiol. 2006 Jan 15;97(2):192-4. doi: 10.1016/j.amjcard.2005.08.023. Epub 2005 Nov 17.
6
GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention.
Catheter Cardiovasc Interv. 2004 Feb;61(2):185-9. doi: 10.1002/ccd.10763.
7
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Circulation. 2003 Oct 7;108(14):1682-7. doi: 10.1161/01.CIR.0000091201.39590.CB. Epub 2003 Sep 22.
8
Inflammation in atherosclerosis.
Nature. 2002;420(6917):868-74. doi: 10.1038/nature01323.
9
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
Nat Med. 2003 Jan;9(1):61-7. doi: 10.1038/nm810. Epub 2002 Dec 16.
10
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).
J Am Coll Cardiol. 2002 Dec 4;40(11):1935-42. doi: 10.1016/s0735-1097(02)02562-7.
Zotero 插件